Professor Stephen (Steve) Wilton

Prof Steve Wilton, C/Prof Allan Kermode, Dr Rakesh Veedu, Prof Sue Fletcher and Dr May Thandar Aung-Htut received $50,000 from MS Research Australia for “Blocking genes to treat MS”.

Targeted alternative splicing: a common therapeutic platform to treat inherited diseases Wilton, Fletcher, Zheng, Mastaglia 2018-2020 $798,165. NHMRC Application 1144791

Targeted alternative splicing: a common therapeutic platform to treat inherited diseases Wilton, Fletcher, Zheng, Mastaglia 2018-2020 $798,165. NHMRC Application 1144791

NHMRC European Union RD-CONNECT: An integrated platform connecting registries, biobanks and clinical bioinformatics for rare disease research $989,884

MDA USA Oligomer design & validation for DMD: quantum improvements in exon skipping US$300,000

NHMRC Optimization of splice switching therapies to treat Duchenne muscular dystrophy”. Bellgard MI, Wilton SD, Fletcher S. $439,000

NHMRC The L-type calcium as a reporter of successful morpholino oligomer therapy in treatment of Duchenne muscular dystrophy cardiomyopathy”. Hool L, Fletcher S, Wilton SD. $575,558